1. Home
  2. SND vs GLSI Comparison

SND vs GLSI Comparison

Compare SND & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

HOLD

Current Price

$5.07

Market Cap

215.0M

Sector

Industrials

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$15.10

Market Cap

254.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SND
GLSI
Founded
2011
2006
Country
United States
United States
Employees
318
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.0M
254.7M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
SND
GLSI
Price
$5.07
$15.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $57.00
AVG Volume (30 Days)
★ 210.6K
117.9K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
★ 4.93%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.15
N/A
Revenue
★ $330,153,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.80
★ N/A
Revenue Growth
★ 6.03
N/A
52 Week Low
$2.05
$7.78
52 Week High
$5.92
$34.10

Technical Indicators

Market Signals
Indicator
SND
GLSI
Relative Strength Index (RSI) 44.42 42.79
Support Level $4.99 $14.57
Resistance Level $5.11 $19.97
Average True Range (ATR) 0.18 1.44
MACD -0.03 -0.26
Stochastic Oscillator 19.61 19.33

Price Performance

Historical Comparison
SND
GLSI

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics. The company has two reportable segments, Sand and SmartSystems. It derives maximum revenue from Sand segment, which includes both frac sand sales and IPS sales. Geographically, the company derives maximum revenue from United States, followed by Canada.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: